News Press Releases

12 Biggest Mid-Day Losers For Wednesday

LOW, ELTK, HAYN, ZION, NVTAQ, MYMD, VSAT, LNTH | November 16, 2016

Endologix, Inc. (NASDAQ: ELGX) shares dropped 24 percent to $7.47 as the company issued an update on Nellix PMA process. Endologix disclosed that the FDA has requested the company to provide a two-year patient follow-up data from the EVAS-FORWARD IDE study of Nellix System.
Akers Biosciences Inc (NASDAQ: AKER) shares fell 19 percent to $2.35. Akers Biosciences shares have surged 55.44 percent over the past 52 weeks, while the S&P 500 index has gained 6.20 percent in the same period.
PDL BioPharma Inc (NASDAQ: PDLI) dropped 18.6 percent to $3.03 after the company reported a proposed $150 million public offering of new convertible senior notes due 2021.
Eltek Ltd. (NASDAQ: ELTK) shares declined 12.4 percent to $0.937. Eltek posted a Q3 net loss of $0.04 per share, versus a year-ago net profit of $0.06 per share.
InVitae Corp (NYSE: NVTA) shares fell 10.4 percent to $7.64 after the company reported an offering of $40 million common stock.
Lantheus Holdings Inc (NASDAQ: LNTH) shares dropped 9.5 percent to $9.27. Lantheus announced an offering 3 million shares of common stock.
Flexion Therapeutics Inc (NASDAQ: FLXN) shares fell 9.4 percent to $18.38. Flexion Therapeutics reported a proposed public offering of common stock.
Haynes International, Inc. (NASDAQ: HAYN) shares declined 9.2 percent to $39.16. Haynes is expected to announce Q4 results on November 17, 2016. JP Morgan downgraded Haynes International from Overweight to Neutral.
Top Image Systems Ltd. (NASDAQ: TISA) dropped 9.1 percent to $1.55. On November 15, Top Image Systems reported Q3 earnings of $0.02 per share on revenue of $7.7 million.
ViaSat, Inc. (NASDAQ: VSAT) declined 8.8 percent to $73.65. ViaSat reported an offering of 6.5 million shares of common stock.
Lowe's Companies, Inc. (NYSE: LOW) shares fell 3.4 percent to $66.73 as the company reported downbeat results for its third quarter on Wednesday.
Zions Bancorp (NASDAQ: ZION) dropped 3.4 percent to $37.46. Bernstein downgraded Zions Bancorp from Outperform to Market Perform, while Morgan Stanley downgraded the stock from Overweight to Equal-Weight.